1. Home
  2. MRVI vs LYNX Comparison

MRVI vs LYNX Comparison

Compare MRVI & LYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$8.17

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Lyntris Inc. Common Stock

LYNX

Lyntris Inc. Common Stock

N/A

Current Price

$10.80

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MRVI
LYNX
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
MRVI
LYNX
Price
$8.17
$10.80
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$8.50
★ $19.67
AVG Volume (30 Days)
★ 2.4M
421.5K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.29
N/A
EPS
N/A
★ N/A
Revenue
★ $185,743,000.00
N/A
Revenue This Year
$14.01
$35.28
Revenue Next Year
$6.20
$34.08
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.55
$10.27
52 Week High
$9.42
$14.64

Technical Indicators

Market Signals
Indicator
MRVI
LYNX
Relative Strength Index (RSI) 60.70 34.19
Support Level $5.54 N/A
Resistance Level $8.74 $13.74
Average True Range (ATR) 0.47 0.58
MACD 0.08 -0.06
Stochastic Oscillator 98.95 14.09

Price Performance

Historical Comparison
MRVI
LYNX

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About LYNX Lyntris Inc. Common Stock

Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.

Share on Social Networks: